Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr 1:14:1323-1329.
doi: 10.2147/CMAR.S350854. eCollection 2022.

Association of Hypertension and Breast Cancer: Antihypertensive Drugs as an Effective Adjunctive in Breast Cancer Therapy

Yuanyuan Fan #  1 , Nazeer Hussain Khan #  1 , Muhammad Farhan Ali Khan  2 , M D Faysal Ahammad  3 , Tayyaba Zulfiqar  2 , Razia Virk  4 , Enshe Jiang  5
Affiliations

Association of Hypertension and Breast Cancer: Antihypertensive Drugs as an Effective Adjunctive in Breast Cancer Therapy

Yuanyuan Fan et al. Cancer Manag Res. .

Abstract

Breast cancer (BC) is the most common malignancy affecting women, and its incidence in younger women is rising worldwide. Early-onset of BC is a multi-step process involving various biological aggressive tumors such as triple negative and human epidermal growth factor 2 (HER2)-positive cancers. BC prevention is still arduous across the globe. A series of observational studies have established a conclusive non-genetic clinical link between hypertension (HTN) and the development of invasive BC. Those clinical associations have driven a pharmacological seek to use the anti-hypertension (AHTN) drugs as an effective adjunctive in BC therapy. The use of AHTN, especially beta-blockers and thiazides, has been recognized as a potent anti-tumor drug to mitigate BC progression, reduce the side effects of cancer treatment, and stop the reoccurrence of cancer in the survivors. Considering the dire need to disseminate the research on how AHTN drugs can be opted as the effective adjunctive therapy to cure the BC, the current review aimed to provide an update on novel understandings on association and mechanisms of AHTN-drugs against BC as an additional cancer therapy.

Keywords: beta blockers; breast cancer; hypertension; hypertensive drugs; thiazides.

PubMed Disclaimer

Conflict of interest statement

The authors report no other potential conflicts of interest for this work.

Figures

Figure 1
Figure 1
Anti-hypertensive drugs used to relieve the hypertensive patients by their action to respective body organs and physiological process.
Figure 2
Figure 2
Purpose mechanism of action of beta- blocker to kill the progressive breast cancer cells by blocking the adrenergic receptors activation.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. DeSantis CE, Ma J, Gaudet MM, et al. Breast cancer statistics, 2019. CA Cancer J Clin. 2019;69(6):438–451. doi:10.3322/caac.21583 - DOI - PubMed
    1. Moo T-A, Sanford R, Dang C, Morrow M. Overview of breast cancer therapy. PET Clin. 2018;13(3):339–354. doi:10.1016/j.cpet.2018.02.006 - DOI - PMC - PubMed
    1. Fang X, Cao J, Shen A. Advances in anti-breast cancer drugs and the application of nano-drug delivery systems in breast cancer therapy. J Drug Deliv Sci Technol. 2020;57:101662. doi:10.1016/j.jddst.2020.101662 - DOI
    1. Azamjah N, Soltan-Zadeh Y, Zayeri F. Global trend of breast cancer mortality rate: a 25-year study. APJCP. 2019;20(7):2015. doi:10.31557/APJCP.2019.20.7.2015 - DOI - PMC - PubMed
    1. Naeem M, Hayat M, Qamar SA, et al. Risk factors, genetic mutations and prevention of breast cancer. Int J Biosci. 2019;14(4):492–496.